John H. Alexander

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

Renato D. Lópes, Gretchen Heizer, Ronald Aronson et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen et al. · JAMA · 2018 · 1.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

John H. Alexander, Renato D. Lópes, Stefan James et al. · New England Journal of Medicine · 2011 · 997 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

Stefan H. Hohnloser, Ziad Hijazi, Laine Thomas et al. · European Heart Journal · 2012 · 573 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17